Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2019

25.01.2019 | Colorectal Cancer

Impact of Family History on Prognosis of Patients with Sporadic Colorectal Cancer

verfasst von: Soo Young Lee, MD, PhD, Duck-Woo Kim, MD, PhD, Sung Il Kang, MD, Myong Hoon Ihn, MD, Heung-Kwon Oh, MD, Sung-Bum Kang, MD, PhD, Chang Hyun Kim, MD, PhD, Hyeong Rok Kim, MD, PhD, Young Jin Kim, MD, PhD, Jae Kyun Ju, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A family history (FH) of colorectal cancer (CRC) increases the risk for development of CRC, but the impact of FH of CRC on survival from sporadic CRC is unclear. This study investigated the prognostic impact of FH of CRC on the recurrence and survival of patients with sporadic CRC.

Methods

We reviewed the records of patients with sporadic CRC from two tertiary referral hospitals in Korea who underwent surgical resection between May 2007 and September 2013. The clinicopathologic features and oncologic outcomes of those with and without FHs of CRC were compared.

Results

We examined the records of 2960 eligible patients, 163 (5.5%) of whom had first-degree relatives with CRC. Patients with and without FHs of CRC had similar baseline characteristics. Multivariable analysis indicated that a FH of CRC was not significantly associated with disease-free survival but was significantly associated with better overall survival (OS) [adjusted hazard ratio = 0.539, 95% confidence interval (CI) 0.330–0.881, P = 0.014]. Subgroup analysis indicated that females and rectal cancer patients with FHs of CRC had significantly better prognoses. Microsatellite status did not affect the improved survival rate associated with FH.

Conclusions

This study of patients with sporadic CRC indicated that those who had FHs of CRC had better OS but similar cancer recurrence as those who had no FH of CRC. The effect of FH of CRC on OS was independent of microsatellite status. Further studies are needed to identify underlying mechanisms and determine the optimal clinical management of CRC according to FH.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Silva FC, Wernhoff P, Dominguez-Barrera C, Dominguez-Valentin M. Update on hereditary colorectal cancer. Anticancer Res. 2016;36(9):4399–405.CrossRef Silva FC, Wernhoff P, Dominguez-Barrera C, Dominguez-Valentin M. Update on hereditary colorectal cancer. Anticancer Res. 2016;36(9):4399–405.CrossRef
2.
Zurück zum Zitat Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014;109(8):1159–79.CrossRefPubMed Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014;109(8):1159–79.CrossRefPubMed
3.
Zurück zum Zitat Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–87 e3. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–87 e3.
4.
Zurück zum Zitat Lee SY, Kim DW, Lee HS, et al. Low-level microsatellite instability as a potential prognostic factor in sporadic colorectal cancer. Medicine (Baltimore). 2015;94(50):e2260.CrossRefPubMedPubMedCentral Lee SY, Kim DW, Lee HS, et al. Low-level microsatellite instability as a potential prognostic factor in sporadic colorectal cancer. Medicine (Baltimore). 2015;94(50):e2260.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Chan JA, Meyerhardt JA, Niedzwiecki D, et al. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA. 2008;299(21):2515–23.CrossRefPubMedPubMedCentral Chan JA, Meyerhardt JA, Niedzwiecki D, et al. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA. 2008;299(21):2515–23.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Zell JA, Honda J, Ziogas A, Anton-Culver H. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3134–40.CrossRefPubMedPubMedCentral Zell JA, Honda J, Ziogas A, Anton-Culver H. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3134–40.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Birgisson H, Ghanipour A, Smedh K, Pahlman L, Glimelius B. The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer. Fam Cancer. 2009;8(4):555–61.CrossRefPubMed Birgisson H, Ghanipour A, Smedh K, Pahlman L, Glimelius B. The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer. Fam Cancer. 2009;8(4):555–61.CrossRefPubMed
8.
Zurück zum Zitat Kao PS, Lin JK, Wang HS, et al. The impact of family history on the outcome of patients with colorectal cancer in a veterans’ hospital. Int J Colorectal Dis. 2009;24(11):1249–54.CrossRefPubMed Kao PS, Lin JK, Wang HS, et al. The impact of family history on the outcome of patients with colorectal cancer in a veterans’ hospital. Int J Colorectal Dis. 2009;24(11):1249–54.CrossRefPubMed
9.
Zurück zum Zitat Lee SD, Kim BC, Han KS, et al. Influence of family history on survival in patients with colon and rectal cancer. J Dig Dis. 2014;15(3):108–15.CrossRefPubMed Lee SD, Kim BC, Han KS, et al. Influence of family history on survival in patients with colon and rectal cancer. J Dig Dis. 2014;15(3):108–15.CrossRefPubMed
10.
Zurück zum Zitat Kirchhoff AC, Newcomb PA, Trentham-Dietz A, Nichols HB, Hampton JM. Family history and colorectal cancer survival in women. Fam Cancer. 2008;7(4):287–92.CrossRefPubMed Kirchhoff AC, Newcomb PA, Trentham-Dietz A, Nichols HB, Hampton JM. Family history and colorectal cancer survival in women. Fam Cancer. 2008;7(4):287–92.CrossRefPubMed
11.
Zurück zum Zitat Phipps AI, Ahnen DJ, Campbell PT, et al. Family history of colorectal cancer is not associated with colorectal cancer survival regardless of microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1700–4.CrossRefPubMedPubMedCentral Phipps AI, Ahnen DJ, Campbell PT, et al. Family history of colorectal cancer is not associated with colorectal cancer survival regardless of microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1700–4.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Slattery ML, Kerber RA. The impact of family history of colon cancer on survival after diagnosis with colon cancer. Int J Epidemiol. 1995;24(5):888–96.CrossRefPubMed Slattery ML, Kerber RA. The impact of family history of colon cancer on survival after diagnosis with colon cancer. Int J Epidemiol. 1995;24(5):888–96.CrossRefPubMed
13.
Zurück zum Zitat Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS. Family history and survival after colorectal cancer diagnosis. Cancer. 2008;112(6):1222–9.CrossRefPubMed Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS. Family history and survival after colorectal cancer diagnosis. Cancer. 2008;112(6):1222–9.CrossRefPubMed
14.
Zurück zum Zitat Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767–74.CrossRefPubMed Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767–74.CrossRefPubMed
15.
Zurück zum Zitat Kim CH, Huh JW, Kim HR, Kim YJ. Prognostic comparison between number and distribution of lymph node metastases in patients with right-sided colon cancer. Ann Surg Oncol. 2014;21(4):1361–8.CrossRefPubMed Kim CH, Huh JW, Kim HR, Kim YJ. Prognostic comparison between number and distribution of lymph node metastases in patients with right-sided colon cancer. Ann Surg Oncol. 2014;21(4):1361–8.CrossRefPubMed
16.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer Staging Manual. 7th ed. New York: Springer; 2009. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer Staging Manual. 7th ed. New York: Springer; 2009.
17.
Zurück zum Zitat National Comprehensive Cancer Network. Clinical practice guidelines in oncology—genetic/familial high-risk assessment: Colorectal. Accessed 1 Mar 2018. National Comprehensive Cancer Network. Clinical practice guidelines in oncology—genetic/familial high-risk assessment: Colorectal. Accessed 1 Mar 2018.
20.
Zurück zum Zitat Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.CrossRefPubMedPubMedCentral Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331(25):1669–74.CrossRefPubMed Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331(25):1669–74.CrossRefPubMed
22.
Zurück zum Zitat Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96(10):2992–3003.CrossRefPubMed Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96(10):2992–3003.CrossRefPubMed
23.
Zurück zum Zitat Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42(2):216–27.CrossRefPubMed Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42(2):216–27.CrossRefPubMed
24.
Zurück zum Zitat Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med. 2012;156(10):703–9.CrossRefPubMed Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med. 2012;156(10):703–9.CrossRefPubMed
25.
Zurück zum Zitat Schoen RE, Razzak A, Yu KJ, et al. Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology. 2015;149(6):1438–45 e1. Schoen RE, Razzak A, Yu KJ, et al. Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology. 2015;149(6):1438–45 e1.
26.
Zurück zum Zitat Duffy SW, Nagtegaal ID, Wallis M, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol. 2008;168(1):98–104.CrossRefPubMed Duffy SW, Nagtegaal ID, Wallis M, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol. 2008;168(1):98–104.CrossRefPubMed
27.
Zurück zum Zitat Humpel N, Magee C, Jones SC. The impact of a cancer diagnosis on the health behaviors of cancer survivors and their family and friends. Support Care Cancer. 2007;15(6):621–30.CrossRefPubMed Humpel N, Magee C, Jones SC. The impact of a cancer diagnosis on the health behaviors of cancer survivors and their family and friends. Support Care Cancer. 2007;15(6):621–30.CrossRefPubMed
28.
Zurück zum Zitat Patterson F, Wileyto EP, Segal J, Kurz J, Glanz K, Hanlon A. Intention to quit smoking: role of personal and family member cancer diagnosis. Health Educ Res. 2010;25(5):792–802.CrossRefPubMed Patterson F, Wileyto EP, Segal J, Kurz J, Glanz K, Hanlon A. Intention to quit smoking: role of personal and family member cancer diagnosis. Health Educ Res. 2010;25(5):792–802.CrossRefPubMed
29.
Zurück zum Zitat Hardikar S, Newcomb PA, Campbell PT, et al. Prediagnostic physical activity and colorectal cancer survival: overall and stratified by tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1130–7.CrossRefPubMedPubMedCentral Hardikar S, Newcomb PA, Campbell PT, et al. Prediagnostic physical activity and colorectal cancer survival: overall and stratified by tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1130–7.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat McCleary NJ, Niedzwiecki D, Hollis D, et al. Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803. Cancer. 2010;116(4):957–66.CrossRefPubMedPubMedCentral McCleary NJ, Niedzwiecki D, Hollis D, et al. Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803. Cancer. 2010;116(4):957–66.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer. 2011;117(21):4948–57.CrossRefPubMedPubMedCentral Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer. 2011;117(21):4948–57.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342(2):69–77.CrossRefPubMed Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342(2):69–77.CrossRefPubMed
33.
Zurück zum Zitat Parc Y, Gueroult S, Mourra N, et al. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut. 2004;53(3):371–5.CrossRefPubMedPubMedCentral Parc Y, Gueroult S, Mourra N, et al. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut. 2004;53(3):371–5.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Fiederling J, Shams AZ, Haug U. Validity of self-reported family history of cancer: a systematic literature review on selected cancers. Int J Cancer. 2016;139(7):1449–60.CrossRefPubMed Fiederling J, Shams AZ, Haug U. Validity of self-reported family history of cancer: a systematic literature review on selected cancers. Int J Cancer. 2016;139(7):1449–60.CrossRefPubMed
35.
Zurück zum Zitat Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292(12):1480–9.CrossRefPubMed Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292(12):1480–9.CrossRefPubMed
Metadaten
Titel
Impact of Family History on Prognosis of Patients with Sporadic Colorectal Cancer
verfasst von
Soo Young Lee, MD, PhD
Duck-Woo Kim, MD, PhD
Sung Il Kang, MD
Myong Hoon Ihn, MD
Heung-Kwon Oh, MD
Sung-Bum Kang, MD, PhD
Chang Hyun Kim, MD, PhD
Hyeong Rok Kim, MD, PhD
Young Jin Kim, MD, PhD
Jae Kyun Ju, MD, PhD
Publikationsdatum
25.01.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07179-0

Weitere Artikel der Ausgabe 4/2019

Annals of Surgical Oncology 4/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.